Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development Post author: Post published: June 17, 2024 Post category:uncategorized Ready-to-use kit enables detection of binding antibodies against AAV vectors without the need for serotype-specific assays. You Might Also Like Italian registry sheds light on acute coronary syndromes in women February 19, 2026 KFF Health News’ ‘What the Health?’: Florida limits abortion — for now April 4, 2024 Cryoballoon ablation as effective as radiofrequency for atrial fibrillation in heart failure patients September 2, 2024
Cryoballoon ablation as effective as radiofrequency for atrial fibrillation in heart failure patients September 2, 2024